Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-cyprindiol 2000microgram/35microgram tablets
1306020C0AAAAAA
|
Co-cyprindiol | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | 9,657 |
|
Dianette tablets (Bayer)
1306020C0BBAAAA
|
Dianette | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | 6,771 |
|
Clairette 2000/35 tablets
1306020C0BFAAAA
|
Clairette | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | 1,373 |
|
Acnocin 2000microgram/35microgram tablets
1306020C0BCAAAA
|
Acnocin | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
Cicafem 2000/35 tablets
1306020C0BEAAAA
|
Cicafem | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
Dianette tablets (Mylan)
1306020C0BBABAA
|
Dianette | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
Diva 2000/35 tablets
1306020C0BDAAAA
|
Diva | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
Teragezza 2000microgram/35microgram tablets
1306020C0BGAAAA
|
Teragezza | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.